Welcome to European Tribune. It's gone a bit quiet around here these days, but it's still going.
Italy delays €15 million `dementia fund' while disease costs billions
Another aspect to consider, according to Vanacore, is the fragility of the diagnostic category of `mild cognitive impairment' (MCI), the condition of the patients on which aducanumab focuses.

The registration studies of the drug [Biogen Aduhelm (aducanumab)], in fact, involve 80% of patients diagnosed with MCI and 20% of patients with mild dementia.

MCI is a clinical condition characterised by a slight difficulty in one or more cognitive domains (for example, memory, attention or language): those affected face difficulties in delivering complex tasks that before they always performed without difficulty, such as managing their financial affairs. But day-to-day activities are not compromised.

Whatever it takes
"For this reason we have decided to eliminate for the last quarter of the year the system costs for gas for everyone, and for electricity for families and small companies."
by Cat on Fri Sep 24th, 2021 at 06:54:47 PM EST
[ Parent ]

Others have rated this comment as follows:


Occasional Series